Brinzolamide

FDA Approved: * November 27, 2020
Pharm Company: * WATSON LABS INC
Category: Vision / Eye Health

Brinzolamide (trade names Azopt, Alcon Laboratories, Befardin,[2] Fardi Medicals,[3] ) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide was approved as a generic medication in the United States in November 2020.[4] Contents 1 Chemistry 2 Indications 3 Pharmacodynamics 4 Pharmacokinetics 4.1 Absorption 4.2 Distribution 4.3 Metabolism 4.4 Excretion 5... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Brinzolamide 10 mg/ml Ophthalmic Suspension/ Drops
NDC: 0591-2127
Labeler:
Actavis Pharma, Inc.
Brinzolamide 10 mg/ml Ophthalmic Suspension/ Drops
NDC: 0781-6014
Labeler:
Sandoz Inc
Brinzolamide 10 mg/ml Ophthalmic Suspension/ Drops
NDC: 24208-464
Labeler:
Bausch & Lomb Incorporated
Brinzolamide 10 mg/ml Ophthalmic Suspension/ Drops
NDC: 63629-8793
Labeler:
Bryant Ranch Prepack
Brinzolamide 10 mg/ml Ophthalmic Suspension/ Drops
NDC: 68682-464
Labeler:
Oceanside Pharmaceuticals.

Related Brands

Drugs with the same active ingredients